Artículos por temáticas

Risk Factors and Metabolism of Different Brain Regions by Positron Emission Tomography in Parkinson Disease with Disabling Dyskinesia

Wei H, Zhou Y, Zhao J, Zhan L.

Curr Neurovasc Res. 2019 Oct 8. doi: 10.2174/1567202616666191009102112. [Epub ahead of print]

Evaluating reflexive saccades and UDPRS as markers of Deep Brain Stimulation and Best Medical Treatment improvements in Parkinson's disease patients: a prospective controlled study.

Szlufik S, Przybyszewski A, Dutkiewicz J, Mandat T, Habela P, Koziorowski D.

Neurol Neurochir Pol. 2019;53(5):341-347. doi: 10.5603/PJNNS.a2019.0045. Epub 2019 Oct 17.

Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.

Kim R, Yoo D, Choi JH, Shin JH, Park S, Kim HJ, Paek SH, Jeon B.

Parkinsonism Relat Disord. 2019 Sep 30;68:73-78. doi: 10.1016/j.parkreldis.2019.09.027. [Epub ahead of print]

Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease.

Adler CH, Serrano GE, Zhang N, Hinni ML, Lott DG, Mehta SH, Sue LI, Intorcia A, Beach TG.

Parkinsonism Relat Disord. 2019 Oct 7;68:69-72. doi: 10.1016/j.parkreldis.2019.10.006. [Epub ahead of print]

Education level affects dual-task gait after deep brain stimulation in Parkinson's disease.

Wegrzyk J, Armand S, Chiuvé SC, Burkhard PR, Allali G.

Parkinsonism Relat Disord. 2019 Oct 7;68:65-68. doi: 10.1016/j.parkreldis.2019.10.005. [Epub ahead of print]

The effect of levodopa on saccades - Oxford Quantification in Parkinsonism study.

Lu Z, Buchanan T, Kennard C, FitzGerald JJ, Antoniades CA.

Parkinsonism Relat Disord. 2019 Sep 27;68:49-56. doi: 10.1016/j.parkreldis.2019.09.029. [Epub ahead of print]

Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.

Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Ma

Parkinsonism Relat Disord. 2019 Oct 1;68:40-45. doi: 10.1016/j.parkreldis.2019.09.032. [Epub ahead of print]

Objective impairment of tandem gait in Parkinson's disease patients increases with disease severity.

Sharma R, Pillai L, Glover A, Virmani T.

Parkinsonism Relat Disord. 2019 Sep 26;68:33-39. doi: 10.1016/j.parkreldis.2019.09.023. [Epub ahead of print]

Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarker.

Sampedro F, Martínez-Horta S, Marín-Lahoz J, Pagonabarraga J, Kulisevsky J.

Parkinsonism Relat Disord. 2019 Oct 1;68:22-25. doi: 10.1016/j.parkreldis.2019.09.031. [Epub ahead of print]

A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.

Burbulla LF, Jeon S, Zheng J, Song P, Silverman RB, Krainc D.

Sci Transl Med. 2019 Oct 16;11(514). pii: eaau6870. doi: 10.1126/scitranslmed.aau6870.

A randomized controlled efficacy study of the Medido medication dispenser in Parkinson's disease.

Hannink K, Ter Brake L, Oonk NGM, Wertenbroek AA, Piek M, Vree-Egberts L, Faber MJ, van der Palen J, Dorresteijn LD.

BMC Geriatr. 2019 Oct 16;19(1):273. doi: 10.1186/s12877-019-1292-y.

Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update.

Leta V, Jenner P, Chaudhuri KR, Antonini A.

Expert Opin Drug Saf. 2019 Oct 16. doi: 10.1080/14740338.2019.1681966. [Epub ahead of print]

Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.

Lin Y, Zeng YF, Cai NQ, Lin XZ, Wang N, He J.

Eur Neurol. 2019 Oct 16:1-8. doi: 10.1159/000503421. [Epub ahead of print]

LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

Rocha EM, De Miranda BR, Castro S, Drolet R, Hatcher NG, Yao L, Smith SM, Keeney MT, Di Maio R, Kofler J, Hastings TG, Greenamyre JT.

Neurobiol Dis. 2020 Feb;134:104626. doi: 10.1016/j.nbd.2019.104626. Epub 2019 Oct 13.

Self-reported and experimentally induced self-disgust is heightened in Parkinson's disease: Contribution of behavioural symptoms.

Tsatali M, Overton PG, Vivas AB.

PLoS One. 2019 Oct 16;14(10):e0223663. doi: 10.1371/journal.pone.0223663. eCollection 2019.